VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 183 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $650 | +33.7% | 150,399 | +103.7% | 0.01% | +50.0% |
| Q2 2023 | $486 | -99.5% | 73,822 | +631.0% | 0.00% | +300.0% |
| Q3 2022 | $100,000 | -93.4% | 10,099 | -92.7% | 0.00% | -94.4% |
| Q2 2022 | $1,506,000 | +82.1% | 138,176 | +88.9% | 0.02% | +80.0% |
| Q1 2022 | $827,000 | +17.6% | 73,131 | +63.2% | 0.01% | +42.9% |
| Q4 2021 | $703,000 | +92.1% | 44,815 | +163.1% | 0.01% | +75.0% |
| Q2 2021 | $366,000 | -55.2% | 17,034 | -68.7% | 0.00% | -66.7% |
| Q1 2021 | $817,000 | +383.4% | 54,402 | +322.1% | 0.01% | +500.0% |
| Q4 2020 | $169,000 | -61.9% | 12,887 | -52.2% | 0.00% | -75.0% |
| Q4 2019 | $443,000 | – | 26,968 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |